GLOW Blend – 70mg Lyophilized Powder
- 10mg BPC-157
- 10mg TB-500
- 50mg GHK-Cu
What is GLOW Blend
The GLOW Blend is a potent triple-peptide formulation combining 10mg BPC-157, 10mg TB-500, and 50mg GHK-Cu in a single 70mg lyophilized vial. This synergistic blend is designed for advanced research into wound healing, skin rejuvenation, and cellular regeneration. Each component targets specific biological pathways, making the blend ideal for studies in aesthetics, repair, and anti-aging science.
Research Based GLOW Blend Known Benefits
- BPC-157 may support research on inflammation reduction and tissue healing
- TB-500 is commonly studied for muscle recovery, angiogenesis, and flexibility
- GHK-Cu is known for its regenerative properties in skin and hair studies
- Combined, these peptides may enhance research on collagen production and cellular repair
- Valuable in studies targeting skin tone, elasticity, and anti-aging effects
Product Features
- Total 70mg lyophilized powder: 10mg BPC-157, 10mg TB-500, 50mg GHK-Cu
- Research-grade blend for advanced skin and recovery studies
- Convenient all-in-one peptide formulation
- Ideal for research involving tissue repair, anti-aging, and regeneration
- Securely sealed to ensure purity and stability during handling
BPC‑157
Preclinical Healing & Regeneration Studies:
- Tendon healing (rats): Accelerated outgrowth of tendon fibroblasts, improved cell survival and migration via FAK-paxillin pathway in Achilles tendon explants
- Nerve & soft tissue recovery (rodents): Improved functional recovery and neuroprotection in sciatic nerve transection and brain injury models
- Mechanistic overview: MDPI review emphasizes its angiogenic, anti-inflammatory, and safety profiles across diverse preclinical injury models
TB‑500 (Thymosin β₄ synthetic analog)
Wound Healing & Regeneration Evidence:
- Skin wound model: Topical or IP Tβ4 increased re-epithelialization by 42–61% and collagen deposition in full-thickness wounds
- Dermal repair across models: Accelerated healing in steroid-treated, diabetic, and aged rodents via enhanced tissue regeneration
- Clinical phase II: Improved healing in pressure ulcers, stasis ulcers, and epidermolysis bullosa patients
- Recent white paper summary: Acceleration of wound closure, tissue regeneration, and corneal/diabetic wound improvements described
GHK‑Cu (Copper Peptide)
Regenerative & Healing Studies:
- Mechanistic animal/in vitro evidence: Enhanced collagen, elastin synthesis, MMP regulation, angiogenesis; proven wound healing in rabbits, rats, mice, pigs, and dogs
- Clinical cosmetic study: Topical GHK‑Cu cream increased collagen production (70% vs 50% for vitamin C) and improved skin regeneration & density in 12‑week human trial
- Review of skin regeneration mechanisms: Highlights anti-inflammatory actions and healing processes in various tissues
Safety Disclaimer
This product is intended for research purposes only. It is not intended for human consumption or medical use.
